Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0650

+0.2%

12:36 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Mimbari	6/10/2013 12:58:35 PM
	of 13111

Now what I do believe Mr. NTTG is that you are working on a parallel drug. That's why you want the dosing information. It would also explain why you bash the company and would also explain why you will not give out your credentials. Good luck with your spying. From what I read PVCT just locked up all renditions of the molecule in a patent. My understanding also is that RB is the only molecule that can be toxic to cancer but completely safe to normal tissue and be broad spectrum based on chemistry alone since it does not rely on antigens for local lesional control. I call that checkmate. Good luck with your dead-end research.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next